Abstract
[This corrects the article DOI: 10.1371/journal.pone.0190525.].
Highlights
Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
Summary
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have